[STOK] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[STOK] Stoke Therapeutics, Inc.
Announcement Date
12-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -10.04%
YoY- -159.39%
Quarter Report
STOK's Result
STOK's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -12,959 -11,039 -10,160 -8,604 -7,819 -5,742 -4,282 109.36%
Tax -50 -674 -904 -1,362 -629 0 0 -
NP -12,959 -11,039 -10,160 -8,604 -7,819 -5,742 -4,282 109.36%
Tax Rate - - - - - - - -
Total Cost 12,959 11,039 10,160 8,604 7,819 5,742 4,282 109.36%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.39 -0.34 -0.31 -0.26 -1.54 -0.19 -0.18 67.51%
EPS Diluted -0.39 -0.34 -0.31 -0.26 -1.54 -0.19 -0.18 67.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.